169 filings
Page 5 of 9
8-K
7de79mlcs6wn62
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
mlu ty6exta5ps5sao
2 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
kf6 lld3wz400y7
30 Nov 17
Intrexon Announces Key Management Appointments
12:00am
8-K
xt4wbv
9 Nov 17
Intrexon Announces Third Quarter 2017 Financial Results
12:00am
8-K
3l2nwxipbvmy
16 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
8mr00
9 Aug 17
Intrexon Announces Second Quarter and First Half 2017 Financial Results
12:00am
8-K
8jf4wb0x2zwhmy6l5rwj
30 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
rnx4cqm1ed m0b
16 Jun 17
Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition
12:00am
8-K
gqk8rc gzuv
10 May 17
Intrexon Announces First Quarter 2017 Financial Results
12:00am
8-K
bv4if
27 Apr 17
Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors
12:00am
8-K
xhbor44to 045bz5
31 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
nuq9annrtur e84
10 Mar 17
Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets
12:00am
8-K
ctwp 5i9ev2kc6ofqb
1 Mar 17
Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
nh53kbc8e5k7r4huc
24 Jan 17
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
12:00am
8-K
83x cd3341xt
11 Jan 17
Regulation FD Disclosure
12:00am
8-K
k2cy5rh3i5l cx1r
30 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
sxykgh oi1
9 Nov 16
Intrexon Announces Third Quarter 2016 Financial Results
12:00am
8-K
nodw5
3 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
koxpkzp90bixfi4
9 Aug 16
Intrexon Announces Second Quarter and First Half 2016 Financial Results
12:00am
8-K
cwcf4o r2p4ue
8 Aug 16
Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer
12:00am